US Broker Ratings

UFP Technologies, Inc. (UFPT) Stock Analysis: Exploring a 64% Potential Upside in the Healthcare Sector

For investors eyeing the healthcare sector, UFP Technologies, Inc. (NASDAQ: UFPT) presents a compelling opportunity. With its focus on medical devices and a robust market cap..

Denali Therapeutics Inc. (DNLI) Stock Analysis: 94.94% Potential Upside Beckons Investors

Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company headquartered in South San Francisco, California, has been capturing the attention of investors with its ambitious pipeline targeting..

NovoCure Limited (NVCR) Stock Analysis: A Healthcare Innovator with Nearly 97% Potential Upside

For investors seeking opportunities in the healthcare sector, NovoCure Limited (NASDAQ: NVCR) presents a compelling case with substantial growth potential. This Swiss-based company specializes in the..

Neogen Corporation (NEOG) Stock Analysis: Exploring a 31.51% Potential Upside Amidst Current Market Dynamics

For investors keeping a keen eye on opportunities in the healthcare sector, Neogen Corporation (NASDAQ: NEOG) presents a compelling case. As a prominent player in the..

GeneDx Holdings Corp. (WGS) Stock Analysis: Exploring Solid Revenue Growth and Analyst Enthusiasm

GeneDx Holdings Corp. (WGS), a key player in the genomics sector, has been capturing the attention of investors with its remarkable 45.60% revenue growth. This impressive..

Merus N.V. (MRUS) Stock Analysis: Evaluating the 2.54% Upside Potential in Biotechnology’s Dynamic Landscape

Merus N.V. (MRUS), a Netherlands-based biotechnology company, stands out in the healthcare sector with a market capitalization of $7.17 billion. Specializing in the development of innovative..

Premier, Inc. (PINC) Stock Analysis: Navigating Healthcare’s Complex Landscape with a 2.99% Dividend Yield

Premier, Inc. (NASDAQ: PINC) is a prominent player in the healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $2.32 billion,..

ARS Pharmaceuticals, Inc. (SPRY) Investor Outlook: Unpacking a Potential 227% Upside

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a dynamic player in the biotechnology sector, is currently making waves in the investment community with a potential upside of 227.75%...

Celldex Therapeutics, Inc. (CLDX) Stock Analysis: A Biotech with a 95% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX) has captured the attention of investors with its considerable potential in the biotechnology sector, evidenced by a striking 95.21% upside potential..

Indivior PLC (INDV) Stock Analysis: Promising 17.7% Upside Potential Amidst Rising Demand for Opioid Treatment Solutions

Indivior PLC (INDV), a major player in the healthcare sector, focuses on developing prescription medications for opioid dependence and related disorders. With a market capitalization of..

Belite Bio, Inc (BLTE) Stock Analysis: Navigating the Biotech Frontier with Promising Clinical Trials

Belite Bio, Inc (BLTE), a clinical-stage biopharmaceutical company, has been making waves in the biotechnology sector. With a current market capitalization of $3.27 billion, this San..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 16% Upside Potential and Robust Revenue Growth

LeMaitre Vascular, Inc. (NASDAQ: LMAT) presents an intriguing opportunity for investors focused on the healthcare sector, particularly within the niche of medical instruments and supplies. With..

Immunocore Holdings plc (IMCR) Investor Outlook: Exploring an 85.88% Potential Upside in Biotech

Immunocore Holdings plc (IMCR) stands out in the biotechnology sector, promising significant growth opportunities for investors with its impressive pipeline of immunotherapies. With a current market..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: Exploring a 16.72% Potential Upside with Robust Revenue Growth

Mirum Pharmaceuticals, Inc. (MIRM) is making waves in the biotech sector, attracting investors with its innovative approach to tackling rare and orphan diseases. With a market..

BGM Group Ltd. (BGM) Stock Analysis: Navigating Challenges Amidst a Transformative Healthcare Landscape

In the complex and rapidly evolving landscape of healthcare, BGM Group Ltd. (BGM), a China-based company, stands as a noteworthy player in the specialty and generic..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A Biotech Innovator with a Staggering 187% Potential Upside

Janux Therapeutics, Inc. (JANX) is capturing the spotlight within the biotechnology sector, not only for its innovative approach to cancer treatment but also for its remarkable..

Organon & Co. (OGN) Stock Analysis: Examining the 53% Potential Upside Amidst Healthcare Headwinds

Organon & Co. (NYSE: OGN) is a prominent player in the healthcare sector, specifically within the drug manufacturers industry. With a market capitalization of $1.84 billion,..

Surgery Partners, Inc. (SGRY) Investor Outlook: Unpacking a 34.58% Potential Upside

Surgery Partners, Inc. (NASDAQ: SGRY), a significant player in the medical care facilities industry, stands as a compelling opportunity for investors eyeing the healthcare sector. With..

Select Medical Holdings Corp (SEM) Stock Analysis: Uncovering a 26.67% Potential Upside

Select Medical Holdings Corporation (NYSE: SEM) is making waves in the healthcare sector with its diverse portfolio of medical care facilities. With a market capitalization of..

Kymera Therapeutics, Inc. (KYMR) Stock Analysis: Unveiling a 12% Potential Upside for Biotech Enthusiasts

Kymera Therapeutics, Inc. (NASDAQ: KYMR) is making waves in the biotechnology sector with its innovative approach to drug development, focusing on small molecule therapeutics that leverage..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds